Pharmaceutical stakeholders target draft guidelines for announced drug pricing regulations

News | JESSE CNOCKAERT
Published: Tuesday, 08/13/2019 4:51 pm EDT
Last Updated: Wednesday, 08/14/2019 10:28 am EDT

The changes to the regulations governing the Patented Medicine Prices Review Board (PMPRB) were released Aug. 9. The PMPRB will begin consultations on new draft guidelines for the regulations this fall. (Pixabay photo)

To View the rest of this article, please choose one of the following

If you are already a subscriber

Subscribe to The Lobby Monitor

Sign Up for a free trial

For instant access to the website.

Canadian Nurses Association execs review Hill day: ‘Nurses are advocates for a better Canada. Period.’
Nov. 22, 2024 12:00 am.
VIEW
Canadian Dental Association tops October communication reports thanks to lobby days
Nov. 21, 2024 12:00 am.
VIEW
New name, old lobbying strategy: JDRF is now Breakthrough T1D
Nov. 20, 2024 12:00 am.
VIEW
Communication Reports: Nov. 11, 2024, to Nov. 17, 2024
Nov. 19, 2024 12:00 am.
VIEW
Peel Police join registry to advocate for broadband network
Nov. 18, 2024 12:00 am.
VIEW

SEE A SAMPLE

READY TO SUBSCRIBE?

Lobby Monitor Subscribers receive:

·
Analysis of Lobbying campaigns and the people behind them
·
Detailed Reports on Lobby Registry activity in an easy to read format
·
Profiles of Key players in the industry in Ottawa and Washington
·
Best Practices and insider tips

These key people read the Lobby Monitor and make decisions that could affect your business:

·
Company CEOs, senior executives who hire GR specialists
·
Law firms and GR firms

·
Public Relations specialists

·
Executives and senior staff

·
Industry and association professionals

·
Academics, researchers and advisers

·
Canadian government leaders, policy experts and senior bureaucrats

·
Provincial government and senior bureaucrats

For more information about The Lobby Monitor, click here or call 613.688.8822.

Pharmaceutical stakeholders target draft guidelines for announced drug pricing regulations

To View the rest of this article, please choose one of the following

If you are already a subscriber

Subscribe to The Lobby Monitor

Sign Up for a free trial

Inside The Lobby Monitor

Subscribers

More Info

Hill Times Publishing

Username
Password